# Bendamustine-based Combination Therapy for PCNSL

> **NCT03392714** · PHASE2 · UNKNOWN · sponsor: **Chonnam National University Hospital** · enrollment: 15 (estimated)

## Conditions studied

- PCNSL

## Interventions

- **DRUG:** R-B(O)AD

## Key facts

- **NCT ID:** NCT03392714
- **Lead sponsor:** Chonnam National University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-01-20
- **Primary completion:** 2018-01-20
- **Final completion:** 2019-01-20
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2018-01-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03392714

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03392714, "Bendamustine-based Combination Therapy for PCNSL". Retrieved via MORVS 2026-10-25 from https://api.morvs.ai/clinical/NCT03392714. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*